SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Orexin Receptor Antagonists and Insomnia · Study

ReviewOrexin Receptor Antagonists and Insomnia

Xin Wu2022

Review2022

Orexin Receptor Antagonists and Insomnia

Xin Wu · Tao Xue · Zhouqing Chen · Zhong Wang · Gang Chen

38 citations·0/0 files stored·Current Psychiatry Reports

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Sleep and related disorders Circadian rhythm and melatonin Sleep and Wakefulness Research

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 38 citations exist upstream.

References

2016Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians 2011Insomnia and the Performance of US Workers: Results from the America Insomnia Survey 2014Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial 2011Insomnia and the Risk of Acute Myocardial Infarction 2019Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder 2010Discovery of the Dual Orexin Receptor Antagonist [(7 R )-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2 H -1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia 2017Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study 2012Orexin receptor antagonism for treatment of insomnia

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2023Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendationsreview · 17 shared references 2021The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysisreview · 14 shared references 2020Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disordersreview · 11 shared references 2023The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trialsreview · 11 shared references 2021Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapiesreview · 10 shared references 2022Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexantreview · 10 shared references

Details

Year2022

Typereview

Published2022-08-16

VenueCurrent Psychiatry Reports

ISSN-L1523-3812

Languageen

Citations38

Files0 public / 0

ShelfSleep and related disorders

Identifiers

doi10.1007/s11920-022-01357-w

openalex_workW4292197069

Links

Imported from OpenAlex (CC0) — nothing here is generated.